A Randomized, Open-label, Three-sequence, Three-period Crossover Study to Investigate The Effect of Anplag on the Disposition of Betaloc in Healthy Male Volunteers

Trial Profile

A Randomized, Open-label, Three-sequence, Three-period Crossover Study to Investigate The Effect of Anplag on the Disposition of Betaloc in Healthy Male Volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 27 Feb 2015

At a glance

  • Drugs Sarpogrelate (Primary) ; Metoprolol
  • Indications Arterial occlusive disorders; Myocardial infarction; Pain; Raynaud's disease; Respiratory tract disorders
  • Focus Pharmacokinetics
  • Most Recent Events

    • 24 Feb 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
    • 25 Jun 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top